Skip to Main Content

Author Details

Naveen L Pereira
Mayo Clinic
1997
168
38
PMIDPaper TitleJournal TitlePublished Year
36445624Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y<sub>12</sub> Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study.Cardiovasc Drugs Ther2024
35914768Pharmacogenetics of Antiplatelet Therapy.Annu Rev Pharmacol Toxicol2023
37526028Myocardial Fibrosis and Cardiomyopathy Risk: A Genetic Link in the MESA.Circ Heart Fail2023
37800334Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of <i>CDCP1</i> and Cardiac Fibrosis.Circ Res2023
37423567Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy.Int J Cardiol2023
37283829CAR-T Therapy in Lymphoma Patients With Coexisting Cardiomyopathy or Cardiac Lymphomatous Involvement.JACC Case Rep2023
37045502Genetic-Guided Oral P2Y<sub>12</sub> Inhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary Intervention.JACC Cardiovasc Interv2023
37335828Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.Circulation2023
37401491Cardiac Sarcoidosis Mimickers: Genetic Testing in Undifferentiated Inflammatory Cardiomyopathies.Circ Genom Precis Med2023
36472615An intervention strategy to improve genetic testing for dilated cardiomyopathy in a heart failure clinic.Genet Med2023
34923540Shotgun Immunoproteomics for Identification of Nonhuman Leukocyte Antigens Associated With Cellular Dysfunction in Heart Transplant Rejection.Transplantation2022
35699977Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study.JMIR Form Res2022
35699175Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial.J Am Heart Assoc2022
35656806Proteomic Biomarkers of Sacubitril/Valsartan Treatment Response in Heart Failure With Preserved Ejection Fraction: Molecular Insights Into Sex Differences.Circ Heart Fail2022
35449399Point of care CYP2C19 genotyping after percutaneous coronary intervention.Pharmacogenomics J2022
36048306Artificial Intelligence Applied to Cardiomyopathies: Is It Time for Clinical Application?Curr Cardiol Rep2022
35132875ABCD-GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial.J Am Heart Assoc2022
35331649Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.Genet Med2022
35265679Rare Genetic Variants Associated With Myocardial Fibrosis: Multi-Ethnic Study of Atherosclerosis.Front Cardiovasc Med2022
35054016Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study.J Clin Med2022
32558174Effects of mTOR inhibitor-related proteinuria on progression of cardiac allograft vasculopathy and outcomes among heart transplant recipients.Am J Transplant2021
33744207Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y<sub>12</sub> Inhibitor Therapy: A Meta-Analysis.JACC Cardiovasc Interv2021
33549263COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine.Mayo Clin Proc2021
33763259The Role of Genetic Testing in the Evaluation of Dilated Cardiomyopathies.Case Rep Cardiol2021
33706876Heart-After-Liver Transplantation Attenuates Rejection of Cardiac Allografts in Sensitized Patients.J Am Coll Cardiol2021
33866824Clinical Impact of Secondary Risk Factors in <i>TTN</i>-Mediated Dilated Cardiomyopathy.Circ Genom Precis Med2021
34557690Rare TBX4 Variant Causing Pulmonary Arterial Hypertension With Small Patella Syndrome in an Adult Man.JACC Case Rep2021
34670396Genotype-Guided P2Y<sub>12</sub> Inhibitor Therapy After Percutaneous Coronary Intervention: A Bayesian Analysis.Circ Genom Precis Med2021
34353468Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram.Mayo Clin Proc2021
34327881Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure.Korean Circ J2021
33962742Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation.J Card Fail2021
34315782Expanding Spectrum of Desmin-Related Myopathy, Long-term Follow-up, and Cardiac Transplantation.Neurology2021
34315566Artificial Intelligence-Enabled Electrocardiography to Screen Patients with Dilated Cardiomyopathy.Am J Cardiol2021
34088425In reply-COVID-19: Precision Medicine and Vascular Endothelium.Mayo Clin Proc2021
34196079Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias.Eur J Heart Fail2021
33129990Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry.Am Heart J2021
32623598Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics.Cardiovasc Drugs Ther2021
31392960Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction.JACC Heart Fail2020
32173217Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding.J Heart Lung Transplant2020
31605094Genetics of dilated cardiomyopathy: practical implications for heart failure management.Nat Rev Cardiol2020
31171114Predictors and Outcomes of Renal Replacement Therapy After Left Ventricular Assist Device Implantation.Mayo Clin Proc2019
31701791Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices.J Am Heart Assoc2019
31411097Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.J Am Heart Assoc2019
31345101Soluble Neprilysin in the General Population: Clinical Determinants and Its Relationship to Cardiovascular Disease.J Am Heart Assoc2019
31202949Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y<sub>12</sub> Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.JACC Cardiovasc Interv2019
31201105Prognostic Biomarkers for Precision Medicine in Heart Transplant: Is Galectin-3 the One?Rev Esp Cardiol (Engl Ed)2019
31510778Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association.Circ Genom Precis Med2019
31250202Updates on the Genetic Paradigm in Heart Failure.Curr Treat Options Cardiovasc Med2019
30834697Beneficial effects of sacubitril/valsartan in heart failure with reduced ejection fraction: pas à cause du BNP?Eur J Heart Fail2019
31146812Incidence of Malignancies in Patients Treated With Sirolimus Following Heart Transplantation.J Am Coll Cardiol2019
  • 1 - 50 of 168

Recommended Authors

Duke University Medical Center, NC Duke Clinical Research Institute
Career Start Year 2017
Number of shared co-authors 2
University of Florida Gainesville
Career Start Year 2015
Number of shared co-authors 0
Duke University Medical Center, Duke Clinical Research Institute
Career Start Year 2010
Number of shared co-authors 9
UC Davis Medical Center
Career Start Year 2007
Number of shared co-authors 2
The Ohio State University Wexner Medical Center
Career Start Year 2006
Number of shared co-authors 0
Gladstone Institutes
Career Start Year 2004
Number of shared co-authors 0
University of Tennessee Health Sciences Centre
Career Start Year 2003
Number of shared co-authors 11
Ronald Reagan university of california los angeles Medical Center Los Angeles CA.
Career Start Year 2001
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 8
Hospital of the University of Pennsylvania
Career Start Year 1998
Number of shared co-authors 4
Hospital for Sick Children
Career Start Year 1997
Number of shared co-authors 7
University of Florida
Career Start Year 1997
Number of shared co-authors 5
Stanford University
Career Start Year 1993
Number of shared co-authors 13
National and Kapodistrian University of Athens, Attikon University Hospital
Career Start Year 1993
Number of shared co-authors 7
University of California San Diego (university of california san diego)
Career Start Year 1993
Number of shared co-authors 6
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 12
Truth for Health Foundation
Career Start Year 1992
Number of shared co-authors 5
Montreal Heart Institute, Universite de Montreal
Career Start Year 1991
Number of shared co-authors 19
Ronald Reagan university of california los angeles Medical Center
Career Start Year 1989
Number of shared co-authors 3
Tufts Medical Center
Career Start Year 1989
Number of shared co-authors 11
Mission Hospital
Career Start Year 1989
Number of shared co-authors 0
El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute
Career Start Year 1988
Number of shared co-authors 0
University of Pennsylvania Perelman School of Medicine
Career Start Year 1987
Number of shared co-authors 9
Department of Medicine Morehouse School of Medicine Atlanta GE.
Career Start Year 1985
Number of shared co-authors 2
British Heart Foundation Centre of Research Excellence, University of Glasgow
Career Start Year 1983
Number of shared co-authors 8
Vanderbilt University Medical Center
Career Start Year 1980
Number of shared co-authors 9
University and University Hospital Wurzburg
Career Start Year 1976
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 1972
Number of shared co-authors 11
University of Bergen
Career Start Year 1971
Number of shared co-authors 6
Mayo Clinic College of Medicine and Science
Career Start Year 1969
Number of shared co-authors 30

Collaborators

Mayo Clinic
Co-authored papers 13
Mayo Clinic
Co-authored papers 11
Mayo Clinic
Co-authored papers 9
Mayo Clinic
Co-authored papers 8
Mayo Clinic
Co-authored papers 6
National Heart Lung and Blood Institute
Co-authored papers 6
Mayo Clinic
Co-authored papers 6
Cornell University
Co-authored papers 5
Mayo Clinic
Co-authored papers 5
Mayo Clinic
Co-authored papers 5
Mayo Clinic
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Mayo Clinic
Co-authored papers 3
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 3
Duke Molecular Physiology Institute
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
Mayo Clinic
Co-authored papers 2
Vanderbilt University Medical Center.
Co-authored papers 2
University of Maryland
Co-authored papers 2
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 2
Stanford University
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
University of Maryland School of Medicine
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Vanderbilt University School of Medicine
Co-authored papers 2
Co-authored papers 2
St. Jude Children's Research Hospital
Co-authored papers 2